Precision Nanomedicine

A new UQ company aims to change the game for chronic pain patients by delivering new, hyper targeted medication.

One of UQ’s leading COVID-19 vaccine researchers, Associate Professor Keith Chappell, has discovered that the chlamydia epidemic plaguing endangered koala populations in Queensland and NSW is linked to a common virus that likely suppresses koalas’ immune systems.

Tiny ‘live’ brain models are being used at The University of Queensland to study a condition causing high-functioning young people with Down Syndrome to suddenly regress.

AIBN researchers have developed a diagnostic device, called an Immuno-storm chip, that could identify which cancer and COVID-19 patients are at risk of a potentially lethal ‘cytokine storm’.

A startup company developing technology based on University of Queensland (UQ) research has announced it will partner with the US Government to test its needle-free vaccine delivery technology.

AIBN's Professor Kristofer Thurecht and IMB's Professor Robert Parton and are Eureka Prize finalists for their project using VR to solve the problem of visualising complex data.

Most diagnostic methods use costly materials and are time-consuming and expensive to run, but PhD candidate Mostafa Masud and research supervisors Professor Yusuke Yamauchi and Dr MD Shahriar Hossain have developed a cheaper, faster and ultrasensitive biosensor for point-of-care testing.

A novel rapid cancer diagnostic technology with the potential to quickly and easily detect cancer has been licensed for further development.